ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Three senior officers of ADMA Biologics personally certified financial statements that allegedly concealed a channel stuffing scheme and undisclosed related party transactions, exposing them to individual liability under federal securities law. NEW YORK, July 15, 2026 /PRNewswire/ -- Levi...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.